畜牧兽医学报 ›› 2020, Vol. 51 ›› Issue (11): 2886-2894.doi: 10.11843/j.issn.0366-6964.2020.11.027

• 临床兽医 • 上一篇    下一篇

肾复康颗粒对人工诱发鸡肾肿病理模型的炎性细胞因子及IL-1R/NF-κB信号通路的影响

罗艺晨1,2,3, 杨庆昌1, 林春发1, 叶芮伶1, 尚杨斐1, 胡宇1, 刘娟1,2,3*   

  1. 1. 西南大学动物科学学院, 重庆 402460;
    2. 重庆市高校兽医科学工程研究中心中兽药创新研发实验室, 重庆 402460;
    3. 西南大学医学院免疫研究中心, 重庆 402460
  • 收稿日期:2020-03-31 出版日期:2020-11-25 发布日期:2020-11-20
  • 通讯作者: 刘娟,主要从事中兽药研发与药理毒理学研究,E-mail:liujuanb@163.com
  • 作者简介:罗艺晨(1981-),女,重庆合川人,实验师,硕士生,主要从事中兽医药研究,E-mail:luojia_1016@163.com
  • 基金资助:
    国家科技基础专项(2013FY110600-03)

The Effect of Shenfukang Granule on Content of Inflammatory Cytokines and the Signaling Pathway of IL-1R/NF-κB Induced by the Artificial Pathological Model of Chicken Kidney Swelling

LUO Yichen1,2,3, YANG Qingchang1, LIN Chunfa1, YE Ruiling1, SHANG Yangfei1, HU Yu1, LIU Juan1,2,3*   

  1. 1. College of Animal Science, Southwest University, Chongqing 402460, China;
    2. Chinese Veterinary Herbal Drugs Innovation Research Laboratory, University Veterinary Science Engineering Research Center in Chongqing, Chongqing 402460, China;
    3. Center for Immune Research, School of Medicine, Southwest University, Chongqing 402460, China
  • Received:2020-03-31 Online:2020-11-25 Published:2020-11-20

摘要: 旨在探讨肾复康颗粒对鸡肾肿的抗炎机制。将90只健康雏鸡分为空白组(15只)和试验组(75只),试验组通过饲喂自制高钙高蛋白饲料人工复制鸡肾肿模型,造模成功后,随机分为模型组、阳性药物组、肾复康颗粒高、中、低剂量组,每组15只,肾复康颗粒高、中、低剂量组分别饮水给药肾复康颗粒2.0、1.0、0.5 g·L-1,阳性药物组饮水给药苍蓝口服液1.0 mL·L-1,模型组饮水给予生理盐水1.0 mL·L-1,2次·d-1,连用5 d。分别于造模前、后以及末次给药后2 d进行翅下静脉采血,分离血清,采用ELISA法检测血清IL-1、TNF-α、MCP-1、TGF-β1的含量变化;采用RT-PCR法检测肾IL-1R、IκBαNF-κBp65 mRNA的转录。结果显示:与空白组相比,模型组雏鸡血清IL-1、TNF-α、MCP-1、TGF-β1含量显著升高(P<0.05),肾中IL-1R、NF-κBp65 mRNA转录量极显著升高(P<0.01),肾中IκBα mRNA转录量极显著降低(P<0.01)。饮水给药治疗后,肾复康颗粒高、低剂量组和阳性药物组雏鸡血清IL-1、TNF-α、MCP-1、TGF-β1含量显著降低(P<0.05);肾复康颗粒中剂量组肾中IL-1R、NF-κBp65 mRNA转录量极显著降低(P<0.01),肾中IκBα mRNA转录量极显著增加(P<0.01)。肾复康颗粒通过降低肾肿鸡血清中IL-1、TNF-α、MCP-1、TGF-β1中含量,抑制IL-1R/NF-κB信号通路,从而发挥抗炎作用。

关键词: 肾复康颗粒, 肾肿, 抗炎, 转录, IL-1R/NF-κB信号通路

Abstract: The objective of the current study was to explore the anti-inflammatory mechanism of Shenfukang granule on chicken kidney swelling. Ninety healthy chickens were divided into blank group (n=15) and test group (n=75), the test group was replicated by the chicken kidney swelling model through feeding high-calcium and high-protein diet. After successful modeling, the test group was randomly divided into model group, positive drug group, Shenfukang high, medium and low dose group (n=15), Shenfukang granule 2.0, 1.0 and 0.5 g·L-1, positive drug group, drinking water to Canglan oral liquid 1.0 mL·L-1, The drinking water of the model group was given 1.0 mL·L-1 of normal saline for 2 times·d-1 and 5 days. Subpteral venous blood was collected before modeling, after modeling and 2 days after the last administration to isolate the serum. The content changes of serum IL-1, TNF-α, MCP-1 and TGF-β1 content were detected by ELISA. RT-PCR was used to detect renal IL-1R, IκBα, NF-κB mRNA transcription. Results were as follows: Compared with the blank group, the serum contents of IL-1, TNF-1, MCP-1 and TGF-β1 were significantly increased in the model group (P<0.05), the transcription of IL-1R, NF-κBp65 mRNA in kidney was significantly increased (P<0.01), and IκBα mRNA in kidney was significantly decreased (P<0.01). After drinking water treatment, the serum IL-1, TNF-α, MCP-1 and TGF-β1 contents of Shenfukang granule were significantly decreased in the high and low dose group and the positive drug group (P<0.01). The results of the current study suggested that Shenfukang granule played an anti-inflammatory role in inhibiting the IL-1R/NF-κB signaling pathway by reducing the contents of IL-1, TNF-α, MCP-1 and TGF-β1 in serum of kidney swelling chicken.

Key words: Shenfukang granule, renal swelling, anti-inflammatory, transcription, IL-1R/NF-κB signaling pathway

中图分类号: